The Central Orthopedic Group, LLP v. Aetna Life Insurance Company

CourtDistrict Court, E.D. New York
DecidedMarch 10, 2026
Docket2:24-cv-03144
StatusUnknown

This text of The Central Orthopedic Group, LLP v. Aetna Life Insurance Company (The Central Orthopedic Group, LLP v. Aetna Life Insurance Company) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
The Central Orthopedic Group, LLP v. Aetna Life Insurance Company, (E.D.N.Y. 2026).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ----------------------------------------------------------- X THE CENTRAL ORTHOPEDIC GROUP, : LLP, : : Plaintiff, : MEMORANDUM DECISION AND : ORDER -against- : : 24-cv-3144 (BMC) AETNA LIFE INSURANCE COMPANY, : : Defendant. : ----------------------------------------------------------- X

COGAN, District Judge.

This is an Employee Retirement Income Security Act (“ERISA”) suit brought by a healthcare provider to recover payment for various orthopedic surgeries. Defendant has moved for summary judgment on the grounds that plaintiff lacks standing and has failed to exhaust administrative remedies, as required by ERISA. For the reasons below, defendant’s motion is denied. BACKGROUND About four years ago, plaintiff, an out-of-network healthcare provider, performed orthopedic surgeries on a patient. As is usually the case, instead of paying the bills himself, the patient executed a document that allowed defendant, the patient’s insurance company, to pay plaintiff directly. Plaintiff charged $325,400 for the surgeries but defendant paid only $1,844. Dissatisfied, plaintiff wrote two letters addressed to defendant’s “APPEALS DEPT” and sought “review” of the “payment that [plaintiff] received” for the surgeries. Plaintiff demanded the “entire claim [to] be re-reviewed and reprocessed.” Defendant replied, acknowledging plaintiff’s “request for an appeal” but noted it lacked “key elements necessary to accurately classify, research and resolve [the] issue.” Defendant’s letter informed plaintiff that, absent any response within “30 days . . . the original adverse determination will be considered final.” Plaintiff did not respond. Thirty-five days later, defendant sent another letter to plaintiff, acknowledging the “request for reconsideration [of the] claim” but concluding that its “original

determination was correct.” Again, plaintiff did not respond, and instead, timely filed suit. DISCUSSION Rule 56 provides that summary judgment is warranted where the moving party “shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). The Court must view all facts “in the light most favorable to the nonmoving party.” Scott v. Harris, 550 U.S. 372, 380 (2007). There is no genuine issue of material fact “where the record taken as a whole could not lead a rational trier of fact to find for” plaintiff. Id. (Plaintiff “must do more than simply show that there is some metaphysical doubt as to the material facts” (quoting Matsushita Elec. Indus. Co. v. Zenith Radio Corp., 475 U.S. 574, 586 (1986))); see also Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 247-48 (1986)

(“the mere existence of some alleged factual dispute between the parties will not defeat a properly supported motion for summary judgment”). Defendant makes two arguments in favor of summary judgement: (1) plaintiff has no standing and (2) plaintiff failed to exhaust administrative remedies. I. Standing Healthcare providers, such as plaintiff, are not “participants” or “beneficiaries” and thus cannot sue under ERISA, unless “a beneficiary has assigned his claim in exchange for health care.” See Simon v. Gen. Elec. Co., 263 F.3d 176, 178 (2d Cir. 2001); Murphy Med. Assoc., LLC v. Yale Univ., 120 F.4th 1107, 1113 (2d Cir. 2024) (“[P]roviders cannot bring claims against ERISA health plans . . . ‘[a]bsent a valid assignment of a claim,’ ‘even if they have a direct stake in the outcome of the litigation.’” (quoting McCulloch Ortho. Surgical Serv., PLLC v. Aetna Inc., 857 F.3d 141, 146 (2d Cir. 2017))). The ERISA plan at issue states the following about assignments:

Assignment of benefits When you direct us to pay your benefits to someone you name, that’s assigning your benefits. When you see a provider they will usually bill us directly. When you assign your benefits to your out-of-network provider, we will pay them directly. A direction to pay a provider is not an assignment of any legal rights.

In other words, the “direction to pay” (1) constitutes an assignment of benefits but (2) does not constitute an assignment of legal rights. The parties do not dispute that the patient directed defendant to pay plaintiff, and only contest the legal effect of the patient having done so. Plaintiff contends that the direction to pay constitutes an “assignment [of the patient’s] claim in exchange for health care,” see Simon, 263 F.3d at 178, such that plaintiff now has standing. Defendant counters that the plan’s use of the phrase “any legal rights” includes the “right to sue,” such that the direction to pay did not confer standing. “This is thus a dispute as to the plain meaning” of the provision, raising a question of ambiguity. See Glickman v. First Unum Life Ins. Co., 676 F. Supp. 3d 257, 261 (S.D.N.Y. 2023). If an “ERISA plan[’s] language is ambiguous, summary judgment is not appropriate.” Eastman Kodak Co. v. Bayer Corp., 576 F. Supp. 2d 548, 550 (S.D.N.Y. 2008) (citing Fay v. Oxford Health Plan, 287 F.3d 96, 104 (2d Cir. 2002)). This is because the Second Circuit “permits a plaintiff to get to a trier of fact based on ambiguous plan language.” See Devlin v. Empire Blue Cross & Blue Shield, 274 F.3d 76, 83 (2d Cir. 2001); see also Bell v. Pfizer, 499 F. Supp. 2d 404, 412 (S.D.N.Y. 2007) (“To survive a motion for summary judgment, a plaintiff need not show that the terms of the [ERISA] plan unambiguously entitle [it] to recovery.”). “Whether contract language is ambiguous is a question of law.” Haber v. St. Paul Guardian Ins. Co., 137 F.3d 691, 695 (2d Cir. 1998). A provision is ambiguous if it “could suggest more than one meaning when viewed objectively by a reasonably intelligent person who has examined the context of the entire integrated agreement and who is cognizant of the customs, practices, usages and terminology as generally understood in the particular trade or business.”

Vale Fox Distillery LLC v. Cent. Mut. Ins. Co., 799 F. Supp. 3d 292, 300-01 (S.D.N.Y. 2025) (quoting Fabozzi v. Lexington Ins. Co., 601 F.3d 88, 90 (2d Cir. 2010)); see also United States Fire Ins. Co. v. General Reins. Corp., 949 F.2d 569, 572 (2d Cir. 1991) (“As with contracts generally, a provision in an insurance policy is ambiguous when it is reasonably susceptible to more than one reading.”). Whether this provision is reasonably susceptible to multiple readings turns on the terms “benefit” and “legal right.” If the plan clearly distinguishes the legal effect of each term, it is possible the plan is not ambiguous. But it does not.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Fabozzi v. Lexington Insurance
601 F.3d 88 (Second Circuit, 2010)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Perreca v. Gluck
295 F.3d 215 (Second Circuit, 2002)
Bell v. Pfizer Inc.
499 F. Supp. 2d 404 (S.D. New York, 2007)
Eastman Kodak Co. v. Bayer Corp.
576 F. Supp. 2d 548 (S.D. New York, 2008)
Heimeshoff v. Hartford Life & Accident Ins. Co.
134 S. Ct. 604 (Supreme Court, 2013)
Devlin v. Empire Blue Cross & Blue Shield
274 F.3d 76 (Second Circuit, 2001)
Murphy Med. Assocs., LLC v. Yale Univ.
120 F.4th 1107 (Second Circuit, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
The Central Orthopedic Group, LLP v. Aetna Life Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/the-central-orthopedic-group-llp-v-aetna-life-insurance-company-nyed-2026.